Dr. Sood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4150 V Street, PSSB, Suite 3400
Sacramento, CA 95817- Is this information wrong?
Summary
- Dr. Namita Sood is a pulmonologist in Sacramento,CA. She received her medical degree from University of Tripoli School of Medicine and has been in practice 29 years. She specializes in critical care medicine and pleural disease and is experienced in interstitial lung disease, critical care medicine, and pulmonary vascular disease.
Education & Training
- University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
- University of Missouri-ColumbiaResidency, Internal Medicine, 1992 - 1995
- University of Tripoli School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 2020 - 2026
- TX State Medical License 2016 - 2021
- OH State Medical License 2001 - 2018
- NC State Medical License 1996 - 2005
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Best Physicians in America 2016
- Excellence in Teaching 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
- The Expression and Significance of MiRNA Start of enrollment: 2008 Jul 01
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.Barberà, J., Jansa, P., Ristić, A., Keogh, A., Solum, D., Rao, Y., Grover, R., Saib, I., Klings, E., Sood, N.> ;Advances in Therapy. 2024 Mar 1
- 4 citationsDelphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.Franck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, Charles D Burger, Murali M Chakinala, Michael S Eggert, Jean M Elwing, Jeremy Feldman, Christopher King, Ja...> ;Pulmonary Circulation. 2022 Apr 1
- Lipoid Pneumonia: Fat Chance of Making the Diagnosis?Namita Sood, Susan Murin> ;Chest. 2021 Aug 1
- Join now to see all
Journal Articles
- Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel ReportKearon C, Akl E A, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King C S, Morris T A, Sood N, Stevens S M, Vintch J, Wells P, Woller S C, Moores L, Chest, 1/1/2016
- Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults CHEST GuidelinesTaichman D, Ornelas J, Chung L, Klinger J, Lewis S Z, Mandel J, Palevsky H, Stuart R, Sood N, Trow T, Yung R E C, Badesch D, Chest, 1/1/2014
- Macitentan for the Treatment of Pulmonary Arterial HypertensionSood N, Expert Opinion On Pharmacotherapy, 1/1/2014
- Join now to see all
Abstracts/Posters
- Results of the Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 MOTION Study of Riociguat in Pulmonary Arterial HypertensionSoodN, Aranda A, Platt D, La Rose A, O Brien G, ATS, 1/1/2017
- Hemodynamic Effects of the Oral Prostacyclin (IP) Receptor Agonist Ralinepag in Pulmonary Arterial Hypertension.Sood N, CHEST, 1/1/2017
- Safety of Ambrisentan in Portopulmonary Hypertension, Result from the AmbrisentaN usaGE in PortopuLmonary Hypertension (ANGEL STUDY)Batterjee W, Burger C, Bartolome S,Safdar Z, Kworka M, Sood N,F Hubert, Gromberg-Maitland M, Chakinala M, Hill N, Preston I, ATS, 1/1/2016
- Join now to see all
Lectures
- Management of Pulmonary Arterial HypertensionBlanchard Valley Hospital, Findlay, OH, 2008; University of Texas Health Science Center at Houston, - 1/1/2017
- Special Consideration Regarding Altiltude/ Flying / Diving.University of Texas Health Science Center at Houston - 1/1/2017
- Case Studies in Pulmonary vascular DiseaseUniversity of Texas Health Science Center at Houston - 1/1/2017
- Join now to see all
Press Mentions
- Reflecting on CHEST 2021November 1st, 2021
Hospital Affiliations
- UC Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: